Krystal Biotech, Inc. KRYS Cost of goods sold
Cost of goods sold at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept krys:CostOfGoodsAndServicesSoldOperating.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s cost of goods sold.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s cost of goods sold?
- Krystal Biotech, Inc. (KRYS) reported cost of goods sold of $6.32M in Q1 2026.
- How has Krystal Biotech, Inc.'s cost of goods sold changed year-over-year?
- Krystal Biotech, Inc.'s cost of goods sold increased by 25.8% year-over-year, from $5.03M to $6.32M.
- What does cost of goods sold mean?
- The direct costs incurred to produce the products or services sold by the company.
- How do you interpret cost of goods sold?
- A decrease relative to revenue suggests improved manufacturing efficiency or economies of scale, while an increase may indicate rising input costs.
- How does cost of goods sold compare across companies?
- Highly dependent on the specific manufacturing process; biotech firms often have low COGS relative to R&D.